Stichting Amsterdam Umc
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Stichting Vumc (to 2024)
Previously recorded as Academisch Medisch Centrum Bij de Universiteit van Amsterdam (to 2024)
7
Ending by 2030
Dec 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 27, 2027The maintenance fee for Methods of Diagnosing and Treating Heart Failure (US 10,393,754) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
- 1 fee due Mar 8, 2027The maintenance fee for Means and methods for influencing the stability of antibody producing cells (US 9,127,251) comes due Mar 8, 2027. Unpaid by Sep 8, 2027, it lapses early.
- 3 fees due Apr 8 to 29, 2027 · next Apr 8
- 1 fee due May 10, 2027The maintenance fee for Method for suppressing an immune response (US 9,180,182) comes due May 10, 2027. Unpaid by Nov 10, 2027, it lapses early.
- 2 fees due Sep 17 to 22, 2027 · next Sep 17
Recent changes
- 1 of the patents on this record was granted since Aug 20, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,273,454 | Means and Methods for Influencing the Stability of Antibody Producing Cells In force · Low confidence | In force | Low confidence | |
| US 9,822,339 | Means and methods for influencing the stability of antibody producing cells In force · From the USPTO record | In force | From the USPTO record | |
| US 8,318,149 | Replication competent viruses capable of silencing virus inhibitory factor expression In force · From the USPTO record | In force | From the USPTO record | |
| US 9,005,974 | Means and Methods for Influencing the Stability of Cells In force · High confidence | In force | High confidence | |
| US 8,180,148 | Imaging apparatus and method of forming composite image from a plurality of source images In force · From the USPTO record | In force | From the USPTO record | |
| US 8,712,762 | Noise suppression in speech signals In force · From the USPTO record | In force | From the USPTO record | |
| US 9,127,251 | Means and methods for influencing the stability of antibody producing cells In force · From the USPTO record | In force | From the USPTO record | |
| US 9,290,765 | Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (ARG) In force · From the USPTO record | In force | From the USPTO record | |
| US 10,174,364 | Method of analysing a blood sample of a subject for the presence of a disease marker In force · From the USPTO record | In force | From the USPTO record | |
| US 9,004,689 | Apparatus for corneal shape analysis and method for determining a corneal thickness In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 35: 4 patents in force now held by others · 2 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 1 no status recorded